Cytokine effect on fibronectin release by retinal pigment epithelial cells

References

• Jerdan J. A., Pepose J. S., Michels R. G., Hayashi H., De Bustros S., Sebag M., Glaser B. M. Proliferative vitreoretinopathy membranes: an immunohistochemical study. Ophthalmology 1989; 96: 801–810
   PubMed Web of Science ®Google Scholar
• Yamakawa R., Shirakawa H., Okada M., Yoshimura N., Matsumura M., Ogino N. Retinal pigment epithelial cells produce fibronectin. Ophthalmic Res. 1987; 19: 338–343
   PubMed Web of Science ®Google Scholar
• Weller M., Wiedemann P., Bresgen M., Heimann K. Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes. Int. Ophthalmol. 1991; 15: 103–108
   PubMed Web of Science ®Google Scholar
• Weller M., Wiedemann P., Bresgen M., Heimann K. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy. Int. Ophthalmol. 1991; 15: 93–101
   PubMed Web of Science ®Google Scholar
• Esser P., Weller M., Heimann K., Wiedemann P. Vitronektin-und Fibronektinrezeptoren bei proliferativen Netzhauterkrankungen. Fortschr. Ophthalmol. 1990; 87: 344–347
   PubMedGoogle Scholar
• Limb G. A., Little B. C., Meager A., Ogilvie J. A., Wolstencroft R. A., Franks W. A., Chignell A. H., Dumonde D. C. Cytokines in proliferative vitreoretinopathy. Eye 1991; 5: 686–693
   PubMedGoogle Scholar
• Gaudric A., Glacet-Bernard A., Clement G., Falquerho L., Barritault D., Coscas G. Transforming growth factor beta dans le vitre de patients presentant une proliferation epiretinienne. Ophtalmologie 1990; 4: 51–52
   PubMedGoogle Scholar
• Connor T. B., Jr, Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., De Bustros S., Enger C., Kato H., Lansing M., Hayashi H., Glaser B. M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Invest. 1989; 83: 1661–1666
   PubMed Web of Science ®Google Scholar
• Morino L., Hiscott P., McKechnie N., Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue, fir. J. Ophthalmol. 1990; 74: 393–399
   Web of Science ®Google Scholar
• Hiscott P., Waller H. A., Grierson I., Butler M. G., Scott D. L., Gregor Z., Morino I. Fibronectin synthesis in subretinal membranes of proliferative vitreoretinopathy. fir. J. Ophthalmol. 1992; 76: 486–490
   Web of Science ®Google Scholar
• Nolle B., Halene M., Zavazava N., Westphal E., Duncker G., Muller-Ruchholtz W. Postmortale serologische und biochemische HLA-Typisierung mit kultivierten retinalen Pigmentepithelzellen (RPE). Fortschr. Ophthalmol. 1991; 88: 629–632
   PubMedGoogle Scholar
• McKechnie N. M., Boulton M., Robey H. L., Savage F., Grierson I. The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo. J. Cell Sci. 1988; 91: 303–312
   PubMed Web of Science ®Google Scholar
• Rasmussen L. M., Heickendorff L. Quantification of fibronectin in extracts of human aortae by an ELISA. Scandinavian J. Clin. Lab. Invest. 1989; 49: 205–210
   PubMed Web of Science ®Google Scholar
• Carsons S. E. The structure and function of fibronectins. Fibronectin in Health and Disease, S. E. Carsons. CRC Press, Inc., Boca Raton, Florida 1989; 1–21
   Google Scholar
• Granstein R. D., Staszewski R., Knisely T. L., Zeira E., Nazareno R., Latina M., Albert D. M. Aqueous humor contains transforming growth factor-β and a small (< 3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 1990; 144: 3021–3027
   PubMed Web of Science ®Google Scholar
• Wahl S. M. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 1992; 12: 61–74
   PubMed Web of Science ®Google Scholar
• Twining S., Potts D., Burke J. Acid proteases of vitreal macrophages. Curr. Eye Res. 1984; 3: 1055–1062
   PubMed Web of Science ®Google Scholar
• Kohase M., May L. T., Tamm I., Vilcek J., Sehgal P. B. A cytokine network in human diploid fibroblasts: interactions of β-interferons, tumor necrosis factor, platelet derived growth factor, and interleukin-1. Mol. Cell. Biol. 1987; 7: 273–280
   PubMed Web of Science ®Google Scholar
• Weller M., Wiedemann P., Heimann K., Zilles K. Fibronectin quantification in plasma and vitreous by a noncompetitive ELISA technique. Doc. Ophthalmol. 1988; 69: 341–351
   PubMed Web of Science ®Google Scholar
• Yeo J. H., Sadeghi J., Campochiaro P. A., Green W. R., Glaser B. M. Intravitreous fibronectin and platelet-derived growth factor: new model for traction retinal detachment. Arch. Ophthalmol. 1986; 104: 417–421
   PubMedGoogle Scholar
• Campochiaro P. A., Jerdan J. A., Glaser B. M. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch. Ophthalmol. 1984; 102: 1830–1833
   PubMedGoogle Scholar
• Varga J., Olsen A., Herhal J., Constantine G., Rosenbloom J., Jimenez S. A. Interferon-g reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts. Eur. J. Clin. Invest. 1990; 20: 487–493
   PubMed Web of Science ®Google Scholar
• Ramadori G., Knittel T., Odenthal M., Schwogler S., Neubauer K., Meyer zum Buschenfelde K. H. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology 1992; 103: 1313–1321
   PubMed Web of Science ®Google Scholar
• Nickoloff B. J., Mitra R. S., Riser B. L., Dixit V. M., Varani J. Modulation of keratinocyte motility: correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am. J. Pathol. 1988; 132: 543–551
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B. The transforming growth factor-βs. Peptides growth factors and their receptors I, Handbook of Experimental Pharmacology, M. B. Sporn, A. B. Roberts. Springer-Verlag, Berlin 1990; Vol. 95: 419–472
   Google Scholar
• Alexander J. P., Bradley J. M. B., Gabourel J. D., Acott T. S. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2520–2528
   PubMed Web of Science ®Google Scholar
• Siren V., Stephens R. W., Salonen E. M., Vaheri A., Summanen P., Immonen I. Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1. Ophthalmic Res. 1992; 24: 203–212
   PubMed Web of Science ®Google Scholar
• Raymond M. C., Thompson J. T. RPE-mediated collagen gel contraction. Inhibition by colchicine and stimulation by TGF-beta. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1079–1086
   PubMed Web of Science ®Google Scholar
• Hagiwara T., Suzuki H., Kono I., Kashiwagi H., Akiyama Y., Onozaki K. Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. Am. J. Pathol. 1990; 136: 39–47
   PubMed Web of Science ®Google Scholar
• Studer R. K., Craven P. A., DeRubertis F. R. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 1993; 42: 118–126
   PubMed Web of Science ®Google Scholar
• Opas M., Dziak E. Effect of TGF-beta on retinal pigmented epithelium in vitro. Exp. Cell Biol 1989; 57: 206–212
   PubMedGoogle Scholar
• Planck S. R., Andresevic J., Chen C., Holmes D. L., Rodden W., Westra I., Wu S. C., Huang X. N., Kay G., Wilson D. J., Robertson E., Rosenbaum J. T. Expression of growth factor mRNA in rabbit PVR model systems. Curr. Eye Res., 11: 1031–1039
   PubMed Web of Science ®Google Scholar